Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4843563

Brc1cnc2[nH]c(-c3ccc(NCc4ccco4)cc3)nc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.41
KDM4E B2RXH2 7/20 0.41
MAPT P10636 7/20 0.41
GAA P10253 4/20 0.41
TDP1 Q9NUW8 4/20 0.41
CHEK2 O96017 1/20 0.39
RAB9A P51151 6/20 0.37
SMN1; SMN2 Q16637 6/20 0.37
NPC1 O15118 5/20 0.37
POLB P06746 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HPGD P15428 5/20 0.37
LMNA P02545 3/20 0.37
HSD17B10 Q99714 3/20 0.37
TSHR P16473 2/20 0.37
MAPK1 P28482 2/20 0.37
PKM P14618 1/20 0.37
ALOX15 P16050 1/20 0.37
CNR2 P34972 1/20 0.36
HTT P42858 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5260119 0.91 ALDH1A1 (0.42) ALDH1A1KDM4EMAPTGAATDP1
Trifluoroacetic Acid SCHEMBL4839496 0.86 LDHA (0.38) ALDH1A1MAPTGAARAB9ANPC1
Trifluoroacetic Acid SCHEMBL4844112 0.85 ALDH1A1 (0.38) ALDH1A1KDM4EMAPTCHEK2SMN1; SMN2
Trifluoroacetic Acid SCHEMBL4843358 0.84 ABL1 (0.44) ALDH1A1KDM4EMAPTTDP1CHEK2
Trifluoroacetic Acid SCHEMBL4842251 0.84 TPH1 (0.37) L3MBTL1HPGDMMP2MMP9MMP8
Trifluoroacetic Acid SCHEMBL5259763 0.84 MMP2 (0.35) ALDH1A1KDM4EMAPTRAB9ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL4843652 0.82 FFAR1 (0.42) MAPTRAB9ASMN1; SMN2NPC1TP53
Trifluoroacetic Acid SCHEMBL4845670 0.82 FFAR1 (0.42) CHEK2
Trifluoroacetic Acid SCHEMBL4844286 0.81 LDHA (0.35) RAB9ANPC1TP53KMT2AMMP2
Trifluoroacetic Acid SCHEMBL4839090 0.81 GPR6 (0.43) L3MBTL1CNR2MMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 ALDH1A1 1489/4885KDM4E 2903/4885MAPT 3669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.